{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:57:34Z","timestamp":1774789054997,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10637-019-00730-6","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T02:41:22Z","timestamp":1550803282000},"page":"1158-1165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage"],"prefix":"10.1007","volume":"37","author":[{"given":"Hyun-Cheol","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Kyu","family":"Chie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Su","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EunSook","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683\u2013692","journal-title":"Cell"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/448548a","volume":"448","author":"SB Baylin","year":"2007","unstructured":"Baylin SB, Schuebel KE (2007) Genomic biology: the epigenomic era opens. Nature 448:548\u2013549","journal-title":"Nature"},{"key":"730_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nm.2305","volume":"17","author":"M Rodriguez-Paredes","year":"2011","unstructured":"Rodriguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17:330\u2013339","journal-title":"Nat Med"},{"key":"730_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb0107-2","volume":"9","author":"BM Turner","year":"2007","unstructured":"Turner BM (2007) Defining an epigenetic code. Nat Cell Biol 9:2\u20136","journal-title":"Nat Cell Biol"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1182\/blood-2015-07-604512","volume":"127","author":"BJ Wouters","year":"2015","unstructured":"Wouters BJ, Delwel R (2015) Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia. Blood 127:42\u201352","journal-title":"Blood"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13148-015-0157-2","volume":"7","author":"C Nervi","year":"2015","unstructured":"Nervi C, De Marinis E, Codacci-Pisanelli G (2015) Epigenetic treatment of solid tumours: a review of clinical trials. Clin Epigenetics 7:127","journal-title":"Clin Epigenetics"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fgene.2013.00040","volume":"4","author":"M Merrifield","year":"2013","unstructured":"Merrifield M, Kovalchuk O (2013) Epigenetics in radiation biology: a new research frontier. Front Genet 4:40","journal-title":"Front Genet"},{"key":"730_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.radonc.2014.05.001","volume":"111","author":"KM Smits","year":"2014","unstructured":"Smits KM, Melotte V, Niessen HE, Dubois L, Oberije C, Troost EG et al (2014) Epigenetics in radiotherapy: where are we heading? Radiother Oncol 111:168\u2013177","journal-title":"Radiother Oncol"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1748-717X-7-39","volume":"7","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Kim JH, Chie EK, Young PD, Kim IA, Kim IH (2012) DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Radiat Oncol 7:39","journal-title":"Radiat Oncol"},{"key":"730_CR10","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/j.ijrobp.2012.06.005","volume":"84","author":"SH Bae","year":"2012","unstructured":"Bae SH, Kim MS, Cho CK, Kang JK, Lee SY, Lee KN, Lee DH, Han CJ, Yang KY, Kim SB (2012) Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies. Int J Radiat Oncol Biol Phys 84:e469\u2013e474","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1349-7006.2008.01004.x","volume":"100","author":"H Qiu","year":"2009","unstructured":"Qiu H, Yashiro M, Shinto O, Matsuzaki T, Hirakawa K (2009) DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells. Cancer Sci 100:181\u2013188","journal-title":"Cancer Sci"},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1158\/1078-0432.CCR-05-0050","volume":"11","author":"H Dote","year":"2005","unstructured":"Dote H, Cerna D, Burgan WE, Carter DJ, Cerra MA, Hollingshead MG, Camphausen K, Tofilon PJ (2005) Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine. Clin Cancer Res 11:4571\u20134579","journal-title":"Clin Cancer Res"},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/cbr.2012.1170","volume":"28","author":"L Wang","year":"2013","unstructured":"Wang L, Zhang Y, Li R, Chen Y, Pan X, Li G, Dai F, Yang JL (2013) 5-aza-2\u2032-deoxycytidine enhances the radiosensitivity of breast cancer cells. Cancer Biother Radiopharm 28:34\u201344","journal-title":"Cancer Biother Radiopharm"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s12272-012-1019-5","volume":"35","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Kim TH, Seo WS, Yoo SD, Kim IH, Joo SH, Shin S, Park ES, Ma ES, Shin BS (2012) Pharmacokinetics and tissue distribution of psammaplin a, a novel anticancer agent, in mice. Arch Pharm Res 35:1849\u20131854","journal-title":"Arch Pharm Res"},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen J, Bardes EE, Aronow BJ, Jegga AG (2009) ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37:W305\u2013W311","journal-title":"Nucleic Acids Res"},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto SKEGG (2000) Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27\u201330","journal-title":"Nucleic Acids Res"},{"key":"730_CR17","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M (2016) KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44:D457\u2013D462","journal-title":"Nucleic Acids Res"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353\u2013DD61","journal-title":"Nucleic Acids Res"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(00)00387-9","volume":"2","author":"J Jassem","year":"2001","unstructured":"Jassem J (2001) Combined chemotherapy and radiation in locally advanced non-small-cell lung cancer. Lancet Oncol 2:335\u2013342","journal-title":"Lancet Oncol"},{"key":"730_CR20","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/cncr.2820360915","volume":"36","author":"V Vongtama","year":"1975","unstructured":"Vongtama V, Douglass HO, Moore RH, Holyoke ED, Webster JH (1975) End results of radiation therapy, alone and combination with 5-fluorouracil in colorectal cancers. Cancer 36:2020\u20132025","journal-title":"Cancer"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2214\/ajr.126.2.229","volume":"126","author":"TC Lo","year":"1976","unstructured":"Lo TC, Wiley AL Jr, Ansfield FJ, Brandenburg JH, Davis HL Jr, Gollin FF, Johnson RO, Ramirez G, Vermund H (1976) Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. AJR Am J Roentgenol 126:229\u2013235","journal-title":"AJR Am J Roentgenol"},{"key":"730_CR22","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"HM Keys","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154\u20131161","journal-title":"N Engl J Med"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.2165\/11596690-000000000-00000","volume":"71","author":"SH Song","year":"2011","unstructured":"Song SH, Han SW, Bang YJ (2011) Epigenetic-based therapies in cancer: progress to date. Drugs 71:2391\u20132403","journal-title":"Drugs"},{"key":"730_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ijrobp.2008.10.032","volume":"73","author":"H De Schutter","year":"2009","unstructured":"De Schutter H, Kimpe M, Isebaert S, Nuyts S (2009) A systematic assessment of radiation dose enhancement by 5-Aza-2\u2032-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 73:904\u2013912","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1470-2045(05)70246-1","volume":"6","author":"KM Prise","year":"2005","unstructured":"Prise KM, Schettino G, Folkard M, Held KD (2005) New insights on cell death from radiation exposure. Lancet Oncol 6:520\u2013528","journal-title":"Lancet Oncol"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/02841860152619115","volume":"40","author":"RA Gatti","year":"2001","unstructured":"Gatti RA (2001) The inherited basis of human radiosensitivity. Acta Oncol 40:702\u2013711","journal-title":"Acta Oncol"},{"key":"730_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.gene.2012.05.037","volume":"504","author":"A Nogueira","year":"2012","unstructured":"Nogueira A, Catarino R, Faustino I, Nogueira-Silva C, Figueiredo T, Lombo L, Hil\u00e1rio-Silva I, Pereira D, Medeiros R (2012) Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy. Gene 504:279\u2013283","journal-title":"Gene"},{"key":"730_CR28","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1158\/1535-7163.MCT-07-2432","volume":"7","author":"JA Casado","year":"2008","unstructured":"Casado JA, Rio P, Marco E, Garcia-Hernandez V, Domingo A, Perez L, Tercero JC, Vaquero JJ, Albella B, Gago F, Bueren JA (2008) Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin. Mol Cancer Ther 7:1309\u20131318","journal-title":"Mol Cancer Ther"},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/JTO.0b013e318244bdd4","volume":"7","author":"C Papadaki","year":"2012","unstructured":"Papadaki C, Sfakianaki M, Ioannidis G, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J (2012) ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer. J Thorac Oncol 7:663\u2013671","journal-title":"J Thorac Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-019-00730-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:38:07Z","timestamp":1678559887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-019-00730-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s10637-019-00730-6","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}